{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:05:44Z","timestamp":1791324344702,"version":"4.3.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,5,4]],"date-time":"2014-05-04T00:00:00Z","timestamp":1399161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/nm.3544","type":"journal-article","created":{"date-parts":[[2014,5,4]],"date-time":"2014-05-04T13:52:43Z","timestamp":1399211563000},"page":"670-675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":296,"title":["Excessive transforming growth factor-\u03b2 signaling is a common mechanism in osteogenesis imperfecta"],"prefix":"10.1038","volume":"20","author":[{"given":"Ingo","family":"Grafe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica P","family":"Homan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caressa","family":"Lietman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda","family":"Munivez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T Kuber","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Peter","family":"B\u00e4chinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,4]]},"reference":[{"key":"BFnm3544_CR1","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch, F. & Glorieux, F.H. Osteogenesis imperfecta. Lancet 363, 1377\u20131385 (2004).","journal-title":"Lancet"},{"key":"BFnm3544_CR2","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/humu.20799","volume":"29","author":"D Baldridge","year":"2008","unstructured":"Baldridge, D. et al. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum. Mutat. 29, 1435\u20131442 (2008).","journal-title":"Hum. Mutat."},{"key":"BFnm3544_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0945-053X(00)00097-4","volume":"19","author":"A Markmann","year":"2000","unstructured":"Markmann, A., Hausser, H., Schonherr, E. & Kresse, H. Influence of decorin expression on transforming growth factor-\u03b2\u2013mediated collagen gel retraction and biglycan induction. Matrix Biol. 19, 631\u2013636 (2000).","journal-title":"Matrix Biol."},{"key":"BFnm3544_CR4","doi-asserted-by":"crossref","first-page":"32634","DOI":"10.1016\/S0021-9258(18)31681-8","volume":"269","author":"Y Takeuchi","year":"1994","unstructured":"Takeuchi, Y., Kodama, Y. & Matsumoto, T. Bone matrix decorin binds transforming growth factor-\u03b2 and enhances its bioactivity. J. Biol. Chem. 269, 32634\u201332638 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnm3544_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","volume":"127","author":"R Morello","year":"2006","unstructured":"Morello, R. et al. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127, 291\u2013304 (2006).","journal-title":"Cell"},{"key":"BFnm3544_CR6","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1111\/j.1742-4658.2008.06704.x","volume":"275","author":"K Mizuno","year":"2008","unstructured":"Mizuno, K., Peyton, D.H., Hayashi, T., Engel, J. & B\u00e4chinger, H.P. Effect of the -Gly-3(S)-hydroxyprolyl-4(R)-hydroxyprolyl- tripeptide unit on the stability of collagen model peptides. FEBS J. 275, 5830\u20135840 (2008).","journal-title":"FEBS J."},{"key":"BFnm3544_CR7","doi-asserted-by":"publisher","first-page":"e1004121","DOI":"10.1371\/journal.pgen.1004121","volume":"10","author":"EP Homan","year":"2014","unstructured":"Homan, E.P. et al. Differential effects of collagen prolyl 3-hydroxylation on skeletal tissues. PLoS Genet. 10, e1004121 (2014).","journal-title":"PLoS Genet."},{"key":"BFnm3544_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nm.1979","volume":"15","author":"Y Tang","year":"2009","unstructured":"Tang, Y. et al. TGF-\u03b21\u2013induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 15, 757\u2013765 (2009).","journal-title":"Nat. Med."},{"key":"BFnm3544_CR9","doi-asserted-by":"publisher","first-page":"7336","DOI":"10.1073\/pnas.1219748110","volume":"110","author":"T Yang","year":"2013","unstructured":"Yang, T. et al. E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-\u03b2 in the bone microenvironment. Proc. Natl. Acad. Sci. USA 110, 7336\u20137341 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3544_CR10","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1016\/S0021-9258(17)37449-5","volume":"269","author":"SL Dallas","year":"1994","unstructured":"Dallas, S.L. et al. Characterization and autoregulation of latent transforming growth factor \u03b2 (TGF \u03b2) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF \u03b2\u2013binding protein. J. Biol. Chem. 269, 6815\u20136821 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnm3544_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1055\/s-2001-15109","volume":"109","author":"S Hering","year":"2001","unstructured":"Hering, S. et al. TGF\u03b21 and TGF\u03b22 mRNA and protein expression in human bone samples. Exp. Clin. Endocrinol. Diabetes 109, 217\u2013226 (2001).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"BFnm3544_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0006-291X(89)92795-2","volume":"158","author":"RO Oreffo","year":"1989","unstructured":"Oreffo, R.O., Mundy, G.R., Seyedin, S.M. & Bonewald, L.F. Activation of the bone-derived latent TGF \u03b2 complex by isolated osteoclasts. Biochem. Biophys. Res. Commun. 158, 817\u2013823 (1989).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm3544_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1042\/bj3020527","volume":"302","author":"A Hildebrand","year":"1994","unstructured":"Hildebrand, A. et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor \u03b2. Biochem. J. 302, 527\u2013534 (1994).","journal-title":"Biochem. J."},{"key":"BFnm3544_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1083\/jcb.132.1.195","volume":"132","author":"A Erlebacher","year":"1996","unstructured":"Erlebacher, A. & Derynck, R. Increased expression of TGF-\u03b2 2 in osteoblasts results in an osteoporosis-like phenotype. J. Cell Biol. 132, 195\u2013210 (1996).","journal-title":"J. Cell Biol."},{"key":"BFnm3544_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune, E.R. et al. Dysregulation of TGF-\u03b2 activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33, 407\u2013411 (2003).","journal-title":"Nat. Genet."},{"key":"BFnm3544_CR16","doi-asserted-by":"publisher","first-page":"e10560","DOI":"10.1371\/journal.pone.0010560","volume":"5","author":"D Baldridge","year":"2010","unstructured":"Baldridge, D. et al. Generalized connective tissue disease in Crtap\u2212\/\u2212 mouse. PLoS ONE 5, e10560 (2010).","journal-title":"PLoS ONE"},{"key":"BFnm3544_CR17","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1093\/hmg\/dds183","volume":"21","author":"F Thiele","year":"2012","unstructured":"Thiele, F. et al. Cardiopulmonary dysfunction in the osteogenesis imperfecta mouse model Aga2 and human patients are caused by bone-independent mechanisms. Hum. Mol. Genet. 21, 3535\u20133545 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3544_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1136\/jcp.49.8.627","volume":"49","author":"SJ McAllion","year":"1996","unstructured":"McAllion, S.J. & Paterson, C.R. Causes of death in osteogenesis imperfecta. J. Clin. Pathol. 49, 627\u2013630 (1996).","journal-title":"J. Clin. Pathol."},{"key":"BFnm3544_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S8756-3282(00)00269-6","volume":"26","author":"F Rauch","year":"2000","unstructured":"Rauch, F., Travers, R., Parfitt, A.M. & Glorieux, F.H. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone 26, 581\u2013589 (2000).","journal-title":"Bone"},{"key":"BFnm3544_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S8756-3282(02)00790-1","volume":"31","author":"LM Ward","year":"2002","unstructured":"Ward, L.M. et al. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone 31, 12\u201318 (2002).","journal-title":"Bone"},{"key":"BFnm3544_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1210\/er.2004-0001","volume":"26","author":"K Janssens","year":"2005","unstructured":"Janssens, K., ten Dijke, P., Janssens, S. & Van Hul, W. Transforming growth factor-\u03b21 to the bone. Endocr. Rev. 26, 743\u2013774 (2005).","journal-title":"Endocr. Rev."},{"key":"BFnm3544_CR22","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1242\/jcs.113.13.2445","volume":"113","author":"K Fuller","year":"2000","unstructured":"Fuller, K., Lean, J.M., Bayley, K.E., Wani, M.R. & Chambers, T.J. A role for TGF\u03b21 in osteoclast differentiation and survival. J. Cell Sci. 113, 2445\u20132453 (2000).","journal-title":"J. Cell Sci."},{"key":"BFnm3544_CR23","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/nm.2793","volume":"18","author":"L Xian","year":"2012","unstructured":"Xian, L. et al. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat. Med. 18, 1095\u20131101 (2012).","journal-title":"Nat. Med."},{"key":"BFnm3544_CR24","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1093\/emboj\/20.9.2254","volume":"20","author":"T Alliston","year":"2001","unstructured":"Alliston, T., Choy, L., Ducy, P., Karsenty, G. & Derynck, R. TGF-\u03b2\u2013induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J. 20, 2254\u20132272 (2001).","journal-title":"EMBO J."},{"key":"BFnm3544_CR25","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1002\/jbmr.139","volume":"25","author":"JR Edwards","year":"2010","unstructured":"Edwards, J.R. et al. Inhibition of TGF-\u03b2 signaling by 1D11 antibody treatment increases bone mass and quality in vivo. J. Bone Miner. Res. 25, 2419\u20132426 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnm3544_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH704>3.0.CO;2-U","volume":"192","author":"P Sarathchandra","year":"2000","unstructured":"Sarathchandra, P., Pope, F.M., Kayser, M.V. & Ali, S.Y. A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype. J. Pathol. 192, 385\u2013395 (2000).","journal-title":"J. Pathol."},{"key":"BFnm3544_CR27","doi-asserted-by":"publisher","first-page":"44061","DOI":"10.1074\/jbc.M207205200","volume":"277","author":"MA Karsdal","year":"2002","unstructured":"Karsdal, M.A. et al. Matrix metalloproteinase\u2013dependent activation of latent transforming growth factor-\u03b2 controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J. Biol. Chem. 277, 44061\u201344067 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm3544_CR28","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/S0002-9440(10)63612-7","volume":"163","author":"J Gauldie","year":"2003","unstructured":"Gauldie, J. et al. Transfer of the active form of transforming growth factor-\u03b2 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am. J. Pathol. 163, 2575\u20132584 (2003).","journal-title":"Am. J. Pathol."},{"key":"BFnm3544_CR29","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1513\/pats.200908-087RM","volume":"6","author":"RE Morty","year":"2009","unstructured":"Morty, R.E., Konigshoff, M. & Eickelberg, O. Transforming growth factor-\u03b2 signaling across ages: from distorted lung development to chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 6, 607\u2013613 (2009).","journal-title":"Proc. Am. Thorac. Soc."},{"key":"BFnm3544_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1749-6632.2002.tb04649.x","volume":"973","author":"JA Marwick","year":"2002","unstructured":"Marwick, J.A. et al. Cigarette smoke-induced oxidative stress and TGF-\u03b21 increase p21waf1\/cip1 expression in alveolar epithelial cells. Ann. NY Acad. Sci. 973, 278\u2013283 (2002).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnm3544_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0014-5793(94)01044-7","volume":"353","author":"H Hausser","year":"1994","unstructured":"Hausser, H., Groning, A., Hasilik, A., Schonherr, E. & Kresse, H. Selective inactivity of TGF-\u03b2\/decorin complexes. FEBS Lett. 353, 243\u2013245 (1994).","journal-title":"FEBS Lett."},{"key":"BFnm3544_CR32","doi-asserted-by":"publisher","first-page":"21801","DOI":"10.1074\/jbc.C000278200","volume":"275","author":"DR Keene","year":"2000","unstructured":"Keene, D.R. et al. Decorin binds near the C terminus of type I collagen. J. Biol. Chem. 275, 21801\u201321804 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnm3544_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/humu.20429","volume":"28","author":"JC Marini","year":"2007","unstructured":"Marini, J.C. et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum. Mutat. 28, 209\u2013221 (2007).","journal-title":"Hum. Mutat."},{"key":"BFnm3544_CR34","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1074\/jbc.270.6.2776","volume":"270","author":"E Sch\u00f6nherr","year":"1995","unstructured":"Sch\u00f6nherr, E. et al. Interaction of biglycan with type I collagen. J. Biol. Chem. 270, 2776\u20132783 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnm3544_CR35","doi-asserted-by":"publisher","first-page":"33926","DOI":"10.1074\/jbc.R112.379602","volume":"287","author":"D Nikitovic","year":"2012","unstructured":"Nikitovic, D. et al. The biology of small leucine-rich proteoglycans in bone pathophysiology. J. Biol. Chem. 287, 33926\u201333933 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnm3544_CR36","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.4049\/jimmunol.153.5.1936","volume":"153","author":"M Christ","year":"1994","unstructured":"Christ, M. et al. Immune dysregulation in TGF-\u03b2 1\u2013deficient mice. J. Immunol. 153, 1936\u20131946 (1994).","journal-title":"J. Immunol."},{"key":"BFnm3544_CR37","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ki.2011.33","volume":"79","author":"H Trachtman","year":"2011","unstructured":"Trachtman, H. et al. A phase 1, single-dose study of fresolimumab, an anti-TGF-\u03b2 antibody, in treatment-resistant primary focal segmental glomerulosclerosis. Kidney Int. 79, 1236\u20131243 (2011).","journal-title":"Kidney Int."},{"key":"BFnm3544_CR38","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.2174\/138920111798808392","volume":"12","author":"S Lonning","year":"2011","unstructured":"Lonning, S., Mannick, J. & McPherson, J.M. Antibody targeting of TGF-\u03b2 in cancer patients. Curr. Pharm. Biotechnol. 12, 2176\u20132189 (2011).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"BFnm3544_CR39","doi-asserted-by":"publisher","first-page":"e90353","DOI":"10.1371\/journal.pone.0090353","volume":"11","author":"JC Morris","year":"2014","unstructured":"Morris, J.C. et al. Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-\u03b2 (TGF\u03b2) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS One 11, e90353 (2014).","journal-title":"PLoS One"},{"key":"BFnm3544_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1172\/JCI71101","volume":"124","author":"ES Orwoll","year":"2014","unstructured":"Orwoll, E.S. et al. Evaluation of teriparatide treatment in adults with osteogenesis imperfecta. J. Clin. Invest. 124, 491\u2013498 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnm3544_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1359\/jbmr.090720","volume":"25","author":"E Daley","year":"2010","unstructured":"Daley, E. et al. Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model. J. Bone Miner. Res. 25, 247\u2013261 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnm3544_CR42","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4049\/jimmunol.175.1.547","volume":"175","author":"AH Lin","year":"2005","unstructured":"Lin, A.H. et al. Global analysis of Smad2\/3-dependent TGF-\u03b2 signaling in living mice reveals prominent tissue-specific responses to injury. J. Immunol. 175, 547\u2013554 (2005).","journal-title":"J. Immunol."},{"key":"BFnm3544_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1006\/abio.1994.1042","volume":"216","author":"M Abe","year":"1994","unstructured":"Abe, M. et al. An assay for transforming growth factor-\u03b2 using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216, 276\u2013284 (1994).","journal-title":"Anal. Biochem."},{"key":"BFnm3544_CR44","doi-asserted-by":"publisher","first-page":"18880","DOI":"10.1073\/pnas.1005574107","volume":"107","author":"ZH Chen","year":"2010","unstructured":"Chen, Z.H. et al. Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema. Proc. Natl. Acad. Sci. USA 107, 18880\u201318885 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3544_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0076-6879(87)44176-1","volume":"144","author":"D Eyre","year":"1987","unstructured":"Eyre, D. Collagen cross-linking amino acids. Methods Enzymol. 144, 115\u2013139 (1987).","journal-title":"Methods Enzymol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3544","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T12:45:09Z","timestamp":1689165909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,4]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["BFnm3544"],"URL":"https:\/\/doi.org\/10.1038\/nm.3544","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718373681.793497899","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718373681.793494772","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718373681.793509206","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,4]]},"assertion":[{"value":"13 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.K.S. is an employee of Genzyme\/Sanofi.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}